NCT02369393 (PROMETEOII) is a NA clinical trial of Behavioral Activation in Major Depressive Disorder, sponsored by Universitat Jaume I.

Who is sponsoring NCT02369393?

NCT02369393 is sponsored by Universitat Jaume I.

What drugs are being tested in NCT02369393?

Interventions in NCT02369393: Behavioral Activation, Physical Activity.

What condition does NCT02369393 study?

NCT02369393 studies Major Depressive Disorder.

Is NCT02369393 still recruiting?

NCT02369393 is currently completed. Last updated 11 July 2023.

Last reviewed 2023-07-11 · How we verify

NCT02369393: PROMETEOII

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Two Internet Delivered Intervention Programs for Depression: Behavioral Activation vs Physical Activity

Completed NA Last updated 11 July 2023

What this trial tests

NA trial testing Behavioral Activation in Major Depressive Disorder in 80 participants. Completed in 1 February 2023.

Timeline

2 November 2021

Primary endpoint
30 April 2022

1 February 2023

Quick facts

Lead sponsor	Universitat Jaume I
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	80
Start date	2 November 2021
Primary completion	30 April 2022
Estimated completion	1 February 2023
Sites	1 location across Spain

Drugs / interventions tested

Behavioral Activation
Physical Activity

Conditions studied

Major Depressive Disorder — all drugs for Major Depressive Disorder →

Sponsor

Universitat Jaume I — full company profile →

Who can join

18 and older, any sex, with Major Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the clinical and cost-effectiveness of Behavioral Activation (BA) and Physical Activity (PA) for adults with major depressive disorder (MDD) or adjustment disorder with depressive symptomatology with a wait list control group (WL) in Spanish population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Behavioral Activation

Trials testing the same drug.

NCT06696001 — Neuroscience of Psychotherapy for Depression · NA · recruiting
NCT06796608 — Behavioral Activation-Led Activity Engagement for Cancer Empowerment · NA · completed
NCT06273995 — Telehealth Behavioral Activation for Teens · NA · recruiting
NCT05685511 — Behavioral Activation and Medication Optimization For Improving Perioperative Mental Health In Older Adults Undergoing O · NA · completed
NCT05574127 — A Study of Brief Behavioral Activation for the Treatment of Depression in Older Adult Cancer Survivors · Phase 2 · active not recruiting

Other recruiting trials for Major Depressive Disorder

Currently open trials in the same condition.

NCT07219394 — Peer-Delivered Behavioral Activation in a CCBHC · NA · recruiting
NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
NCT06749392 — An Individual-specific Synchrony Signature · NA · recruiting
NCT07316803 — Group Intervention for Romantic Relationships in Young Adults With Severe Mental Illness · NA · recruiting
NCT07242105 — Optimizing Brain Excitability in Depression · NA · recruiting

Other Universitat Jaume I trials

Trials by the same sponsor.

NCT07202975 — RE-SCALE: Rehabilitation Engagement and Scaled Access With eXtended Reality and Artificial Intelligence · NA · not yet recruiting
NCT07345117 — Cost-effectiveness and Implementation of a Transdiagnostic Internet-based Intervention for Emotional Disorders in Commun · NA · not yet recruiting
NCT06932120 — Technology-supported Interventions for Prolonged Grief Disorder (PGD) · NA · recruiting
NCT06788119 — Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders · NA · recruiting
NCT06839573 — Effectiveness of Immersive Virtual Reality in Nursing Students' Learning · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02369393 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universitat Jaume I
Last refreshed: 11 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02369393.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing